Ibrahim Serag | Neuroimaging | Best Researcher Award

Published on by Neuroscientists

Dr. Ibrahim Serag | Neuroimaging | Best Researcher Award

Dr. Ibrahim Serag, Faculty of Medicine Mansoura university, Egypt.

Dr. Ibrahim Hamdino Ibrahim Serag is a dynamic intern doctor, clinical researcher, and emerging neurosurgical leader based in Mansoura, Egypt. With a stellar academic record from Mansoura University Faculty of Medicine, he has consistently demonstrated excellence both in the classroom and in clinical practice. His focused interest in neurosurgery, along with a profound commitment to medical research, has positioned him at the forefront of Egypt’s next generation of clinician-scientists.

Profile

Google Scholar

 

🧠 Early Academic Pursuits

Dr. Ibrahim Serag embarked on his journey in medicine with an unwavering curiosity for the human brain and its intricate workings. From the very beginning of his academic life at Mansoura University Faculty of Medicine, he stood out for his intellectual commitment and passion for neurosurgery. His dedication translated into academic excellence, earning him an impressive GPA of 3.78 and numerous distinctions across all courses. Early in his studies, he was drawn to the field of neurosurgery, not just for its technical challenges but for its potential to dramatically transform patient lives.

🩺 Professional Endeavors

As an intern doctor, Dr. Serag has been immersed in clinical practice while maintaining strong involvement in academic research. His elective neurosurgical rotation at Mansoura University’s hospital offered him valuable, hands-on experience that further fueled his desire to pursue neurosurgery. His professional path also includes significant leadership roles within NEGIDA Academy, where he serves as both a clinical researcher and course co-instructor, reflecting his dedication to both practice and pedagogy.

🔬 Contributions and Research Focus

Dr. Serag has carved a strong niche in neurosurgical research, particularly within the domains of systematic reviews, meta-analyses, and neuroimaging innovations. With over a dozen publications in high-impact journals and an H-index of 5, he has become a recognized voice in clinical neurology and neurosurgical diagnostics. He leads multiple collaborative research groups under Mansoura Manchester Research Society, Tanta University, and TSRA, focusing on evidence-based medicine and the clinical application of neuroscience. His work often explores the comparative effectiveness of neurosurgical techniques such as drainage, irrigation, and anesthetic modalities in chronic subdural hematomas, as well as neuroprotective agents and AI-assisted diagnostics.

🏆 Accolades and Recognition

Dr. Serag’s work has been acknowledged through multiple prestigious awards, reflecting both the depth and innovation of his research. He was honored with the Best Poster Presentation at the 4th and 5th Annual Research Days at Mansoura University, and also at the Alex Neuroscience Conference (ACN 2024). His academic distinction has earned him travel grants for ISA 2024 and ICCN 2024, affirming his growing reputation on both national and international platforms. Additionally, he received honors from university deans, cementing his place among the top emerging minds in his field.

🌍 Impact and Influence

Beyond personal accomplishments, Dr. Serag’s influence resonates through the many research groups he leads and the countless students and young doctors he mentors. His role as a team leader and course co-instructor at NEGIDA Academy enables him to share knowledge and cultivate a culture of inquiry and innovation among Egypt’s next generation of neurosurgeons. His collaborations extend internationally, where he works with senior academics and clinicians to bridge gaps in neuroclinical research and global healthcare accessibility.

📚 Legacy and Future Contributions

With a vision that goes beyond borders, Dr. Serag is determined to pioneer transformational change in neurosurgical research and practice. His future aspirations are deeply rooted in advancing minimally invasive neurosurgical techniques, expanding AI integration in neurodiagnostics, and fostering multinational research networks. As he seeks a neurosurgical residency, his goal remains steadfast: to blend clinical mastery with scholarly rigor, pushing the boundaries of neurological science for generations to come.

 

Publication

  • Title: Drainage versus no drainage after burr-hole evacuation of chronic subdural hematoma: a systematic review and meta-analysis of 1961 patients
    Authors: A Aljabali, AM Sharkawy, B Jaradat, I Serag, NM Al-Dardery, …
    Year: 2023

 

  • Title: Using artificial intelligence to improve body iron quantification: A scoping review
    Authors: AJ Nashwan, IM Alkhawaldeh, N Shaheen, I Albalkhi, I Serag, K Sarhan, …
    Year: 2023

 

  • Title: An updated systematic review of neuroprotective agents in the treatment of spinal cord injury
    Authors: I Serag, M Abouzid, A Elmoghazy, K Sarhan, SA Alsaad, RG Mohamed
    Year: 2024

 

  • Title: Irrigation versus no irrigation in the treatment of chronic subdural hematoma: An updated systematic review and meta-analysis of 1581 patients
    Authors: A Aljabali, I Serag, S Diab, AZ Alhadeethi, M Abdelhady, IM Alkhawaldeh, …
    Year: 2024

 

  • Title: Local anesthesia with sedation and general anesthesia for the treatment of chronic subdural hematoma: a systematic review and meta-analysis
    Authors: MA Abdelhady, A Aljabali, M Al-Jafari, I Serag, A Elrosasy, A Atia, A Ehab, …
    Year: 2024

 

  • Title: Insights into head and neck cancer research in Egypt: A scoping review
    Authors: MH El din Moawad, MM Shalaby, MA Sadeq, M Al-Jafari, JW A’amar, …
    Year: 2023

 

  • Title: Exploring the mechanisms and therapeutic approaches of mitochondrial dysfunction in Alzheimer’s disease: An educational literature review
    Authors: MHED Moawad, I Serag, IM Alkhawaldeh, A Abbas, A Sharaf, S Alsalah, …
    Year: 2024

 

  • Title: Postoperative elevated bed header position versus supine in the management of chronic subdural hematoma: a systematic review and meta-analysis
    Authors: I Serag, M Abdelhady, AA Awad, A Wageeh, A Shaboub, RH Elhalag, …
    Year: 2024

 

  • Title: Neuro-oncological research output in Africa: a scoping review of primary brain tumors
    Authors: MHE Moawad, M Al-Jafari, AM Taha, JW A’amar, O Alsayed, T Fayad, …
    Year: 2024

 

  • Title: Evaluating the efficacy and safety of platelet-rich plasma injection for erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials
    Authors: M Deabes, MG Deameh, BA Bani Irshid, AH Al Darraji, I Serag, …
    Year: 2024

 

🧩 Conclusion

With a rare blend of clinical ambition, research innovation, and academic leadership, Dr. Ibrahim Serag is well on his path to becoming a transformative figure in neurosurgery. His ongoing contributions to evidence-based medicine, along with his global collaborations and scholarly achievements, underline a future filled with promise. Driven by curiosity and compassion, he aims not only to heal patients but to reshape how brain diseases are diagnosed and treated—leaving a lasting impact on the field of neurosurgery.

Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Published on by Neuroscientists

Dr. Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Dr. Kiran Solingapuram Sai, Wake Forest School of Medicine, United States.

Dr. Kiran K. Solingapuram Sai, PhD, is an Associate Professor with tenure in the Department of Radiology at Wake Forest School of Medicine. He holds a Ph.D. in Organic Chemistry from Northern Illinois University and has extensive research experience in radiopharmaceutical chemistry. His postdoctoral training at Washington University’s Mallinckrodt Institute of Radiology focused on radiotracer development.

Profile

Orcid

 

✨ Early Academic Pursuits

Dr. Kiran K. Solingapuram Sai embarked on his academic journey with a strong foundation in chemistry, earning a Bachelor of Science degree in Chemistry, Biochemistry, and Microbiology from Osmania University, Hyderabad, India, in 2001. His passion for organic chemistry led him to pursue a Master of Science in the same field at Osmania University, where he honed his expertise in chemical synthesis and molecular interactions. Determined to explore the depths of organic chemistry, he pursued his Ph.D. at Northern Illinois University, DeKalb, IL, under the mentorship of Dr. Douglas A. Klumpp. During this period, his research focused on synthetic methodologies and organic reaction mechanisms, paving the way for his future contributions to medicinal and radiopharmaceutical chemistry.

🌐 Professional Endeavors

Dr. Sai’s professional journey commenced with a prestigious postdoctoral research associate position at the Mallinckrodt Institute of Radiology at Washington University in St. Louis, MO, where he worked under the guidance of Dr. Robert H. Mach. During his tenure from 2010 to 2013, he delved into the complexities of radiochemistry, developing novel radiotracers and exploring their applications in medical imaging. This experience laid the groundwork for his career in radiopharmaceutical sciences. In 2014, he joined Wake Forest School of Medicine as a Research Instructor and Chief Radiochemist, marking the beginning of his significant contributions to translational imaging and radiopharmaceutical production.

⚛️ Contributions and Research Focus

At Wake Forest School of Medicine, Dr. Sai played a pivotal role in the Department of Radiology and the Clinical Translational Science Institute (CTSI). He specialized in managing clinical and research-based radiopharmaceutical production at the Wake Forest PET Research Center. As a cyclotron manager and coordinator, he oversaw the synthesis and quality control of radiotracers essential for PET imaging. His expertise extended to the development and implementation of cGMP-approved protocols for C-11 and F-18 radiopharmaceutical production, ensuring the highest standards of safety and efficacy. His research focuses on advancing PET imaging techniques, exploring new radiotracers for diagnostic and therapeutic applications, and improving imaging biomarker development.

🏆 Accolades and Recognition

Dr. Sai’s dedication to radiochemistry and molecular imaging has earned him recognition in the scientific community. His work has been instrumental in developing radiopharmaceuticals for neurological and oncological imaging, contributing significantly to early disease detection and targeted therapy. His contributions have been acknowledged through numerous research grants, collaborative projects, and publications in high-impact scientific journals. His commitment to excellence and innovation has positioned him as a leading figure in the field of radiopharmaceutical sciences.

🔬 Impact and Influence

Beyond his research and technical expertise, Dr. Sai has mentored budding scientists and researchers in the field of radiochemistry and imaging sciences. His guidance has helped shape the next generation of radiopharmaceutical experts, fostering a culture of innovation and scientific curiosity. His role in translational imaging programs has bridged the gap between basic research and clinical applications, directly impacting patient care by improving diagnostic imaging techniques.

💡 Legacy and Future Contributions

Dr. Sai’s work continues to inspire advancements in molecular imaging and radiopharmaceutical development. As an Associate Professor with tenure at Wake Forest School of Medicine, he remains dedicated to pushing the boundaries of radiochemistry, developing cutting-edge imaging agents, and enhancing the precision of diagnostic medicine. His legacy in the field is defined by his unwavering commitment to scientific discovery, translational research, and the continuous pursuit of excellence in radiopharmaceutical sciences.Dr. Kiran K. Solingapuram Sai’s contributions to the field of radiopharmaceutical chemistry stand as a testament to his dedication, innovation, and impact on medical imaging and healthcare. His journey from a passionate chemistry student to a distinguished professor and researcher highlights the transformative power of science in shaping the future of medicine.

 

Publication

  1. Radiation-induced brain injury in non-human primates: A dual tracer PET study with [11C]MPC-6827 and [11C]PiB

    • Authors: Naresh Damuka, George W. Schaaf, Mack Miller, Caleb Bradley, Bhuvanachandra Bhoopal, Ivan Krizan, Krishna K. Gollapelli, Christopher T. Whitlow, J. Mark Cline, Kiran K. Solingapuram Sai
    • Year: 2025

 

  1. The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer

    • Authors: Hilal A. Rather, Sameh Almousa, Ashish Kumar, Mitu Sharma, Isabel Pennington, Susy Kim, Yixin Su, Yangen He, Abdollah R. Ghara, Kiran Kumar Solingapuram Sai et al.
    • Year: 2023

 

  1. Development and Optimization of 11C-Labeled Radiotracers: A Review of the Modern Quality Control Design Process

    • Authors: Paul Josef Myburgh, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. Binding Parameters of [11C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents

    • Authors: Avinash H. Bansode, Bhuvanachandra Bhoopal, Krishna Kumar Gollapelli, Naresh Damuka, Ivan Krizan, Mack Miller, Suzanne Craft, Akiva Mintz, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains

    • Authors: Naresh Damuka, Paul W. Czoty, Ashley T. Davis, Michael Nader, Susan H. Nader, Suzanne Craft, Shannon L. Macauley, Lindsey K. Galbo Thomma, Phillip M. Epperly, Christopher T. Whitlow et al.
    • Year: 2020

 

  1. One-pot synthesis of novel tert-butyl-4-substituted phenyl-1H-1,2,3-triazolo piperazine/piperidine carboxylates, potential GPR119 agonists

    • Authors: Nagaraju Bashetti, J.V. Shanmukha Kumar, Naresh Varma Seelam, B. Prasanna, Akiva Mintz, Naresh Damuka, Sriram Devanathan, Kiran Kumar Solingapuram Sai
    • Year: 2019

 

Conclusion

Dr. Kiran K. Solingapuram Sai has established himself as a leading expert in radiopharmaceutical sciences, contributing significantly to translational imaging research. His work in PET radiopharmaceutical production and quality assurance underscores his role in advancing medical imaging techniques. His academic and research contributions make him a valuable asset in the field of radiology and molecular imaging.